BBR PARTNERS, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
BBR PARTNERS, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$91,778
-36.2%
28,9520.0%0.01%
-37.5%
Q2 2023$143,891
+0.6%
28,9520.0%0.02%0.0%
Q1 2023$143,023
-21.5%
28,9520.0%0.02%
-20.0%
Q4 2022$182,108
-41.8%
28,9520.0%0.02%
-50.0%
Q3 2022$313,000
-5.2%
28,9520.0%0.04%
+2.6%
Q2 2022$330,000
+25.0%
28,9520.0%0.04%
+56.0%
Q1 2022$264,000
-72.4%
28,952
-54.8%
0.02%
-77.7%
Q4 2021$955,000
+6.0%
64,005
+82.6%
0.11%
+49.3%
Q3 2021$901,000
-11.4%
35,053
-10.1%
0.08%
-6.2%
Q2 2021$1,017,000
-26.1%
39,0080.0%0.08%
-29.2%
Q1 2021$1,377,00039,0080.11%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders